JULIA LE: Open Payments
NPI 1437833829 · FORT WORTH, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$891 in 46 payments from 13 companies in 2025. Trend: 2023 $191 · 2024 $1,099 · 2025 $891
Food & beverage: $891
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 13 | $213 |
| AstraZeneca Pharmaceuticals LP | 8 | $159 |
| Amgen Inc. | 6 | $109 |
| Inspire Medical Systems, Inc. | 2 | $69 |
| GlaxoSmithKline, LLC. | 3 | $68 |
| Novo Nordisk Inc | 3 | $64 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $53 |
| Hologic Sales and Service, LLC | 1 | $42 |
| Dexcom, Inc. | 2 | $37 |
| Exact Sciences Corporation | 2 | $32 |
Products named: MOUNJARO, JARDIANCE, AIRSUPRA, INSPIRE, KRYSTEXXA, TRELEGY ELLIPTA, FARXIGA, APTIMA.
Industry payments across TX — which companies pay providers there.
